CapsoVision Reports Q3 2026 Revenue of $3.6 million
CapsoVision reported Q3 revenue of $3.6 million and announced the FDA clearance and U.S. launch of its AI Highlights tool, aiming to drive sales growth in the medical technology sector.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed